SterRx

Form 483 issued June 28, 2023 · Plattsburgh, New York

Inspection
Jun 1 – Jun 28, 2023
Observations
7
Pages
11
FEI number
3010840309

In short: On June 28, 2023, FDA issued a Form 483 with 7 observations to SterRx in Plattsburgh, New York (FEI 3010840309) after an inspection that ran Jun 1 – Jun 28, 2023. The investigators were Edmund F. Mrak and Pushpa S. Jayasekara. Most observations concern facilities & equipment and materials.

At a glance

Facilities & equipment and materials account for 5 of 7 observations.

Facilities & equipment4
Materials1
Production1
Laboratory controls1

What FDA observed

Preview: the opening words of each observation
  1. 01

    There was a failure to handle and store components and closures at all times in a…

  2. 02

    Protective apparel is not worn as necessary to protect…

  3. 03

    Aseptic processing areas are deficient regarding the system…

  4. 04

    Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at SterRx?

FDA listed 7 observations on this Form 483, mostly about facilities & equipment, materials and production. The opening words of each observation are shown on this page.

Who inspected SterRx?

Edmund F. Mrak and Pushpa S. Jayasekara are named on this Form 483, for the inspection of Jun 1 – Jun 28, 2023. Each investigator has a profile showing what they cite most.

When was SterRx inspected by FDA?

The inspection ran Jun 1 – Jun 28, 2023, and the Form 483 is dated June 28, 2023.

How do I get the full Form 483 for SterRx?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free